Professor Arlene Chan graduated from the medical school of University of Melbourne, Australia. She obtained her Fellowship in Medical Oncology from the Royal Australasian College of Physicians and a Masters of Medicine in Palliative Care from the University of Melbourne in 1993. Prof Chan received a fellowship in breast cancer/cancer genetics from Princess Margaret Hospital in Toronto and in 1997, she returned to Australia as a consultant medical oncologist at Royal Perth Hospital. Prof Chan has been a breast cancer-specific oncologist at the Mount Hospital since 1999. She is an adjunct professor at the Curtin Health Innovation Research Institute at Curtin University, the director of breast clinical trials unit at the Mount Hospital, and vice chair of the Breast Cancer Research Centre of WA. Prof Chan also serves on the academic steering committee of several breast cancer trials and sits on the national and international advisory board for several pharmaceutical companies dealing with breast cancer treatments. She has authored more than 100 publications and her interests include clinical research in understanding biological determinants of therapeutic response, optimising symptomatic care in early and advanced breast cancer, and developing data collection systems for clinical research and measuring patient outcomes.
